STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Sargramostim |
Recruiting |
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission |
Laboratory Biomarker Analysis, Sargramostim, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine |
Active, not recruiting |
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens |
Bazedoxifene and Conjugated Estrogens |
Recruiting |
An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial |
|
Active, not recruiting |
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe |
VIA and thermocoagulation |
Active, not recruiting |
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate |
Recruiting |
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants |
Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine |
Active, not recruiting |
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer |
Biopsy, Extended Release Metformin Hydrochloride, Megestrol Acetate, Questionnaire Administration |
Recruiting |
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer |
Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration |
Active, not recruiting |
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer |
Biospecimen Collection, Retinoid 9cUAB30, Therapeutic Conventional Surgery |
Active, not recruiting |